| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 536290100 | Nitrogen of N-glycoside is acyclic nitrogen | 7 |
| 20080214801 | CHEMOSELECTIVE LIGATION - The present invention features a chemoselective ligation reaction that can be carried out under physiological conditions. In general, the invention involves condensation of a specifically engineered phosphine, which can provide for formation of an amide bond between the two reactive partners resulting in a final product comprising a phosphine moiety, or which can be engineered to comprise a cleavable linker so that a substituent of the phosphine is transferred to the azide, releasing an oxidized phosphine byproduct and producing a native amide bond in the final product. The selectivity of the reaction and its compatibility with aqueous environments provides for its application in vivo (e.g., on the cell surface or intracellularly) and in vitro (e.g., synthesis of peptides and other polymers, production of modified (e.g., labeled) amino acids). | 09-04-2008 |
| 20090176978 | QUARTERNIZED AMINO GLUCOSAMINE COMPOUND FOR EXERTING ANTICANCER EFFECT - The present invention relates to the quarternized amino glucosamine, it can exert an anticancer effect via induction of apoptosis in a dose and time dependant manner through which an anticancer treatment effect can be increased. | 07-09-2009 |
| 20100311962 | Agents For Magnetic Imaging Method - The invention provides MRI detectable species of formula (I) | 12-09-2010 |
| 536290110 | N-hetero ring bonded directly or indirectly to the acyclic nitrogen | 1 |
| 20140378677 | VERSION OF FDG DETECTABLE BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY - A compound comprising a metal chelate linked to a hexose carrier for use as a metallopharmaceutical diagnostic or therapeutic agent is provided. The compound is suitable for imaging by single-photon emission computed tomography, computer assisted tomography, magnetic resonance spectroscopy, magnetic resonance imaging, positron emission tomography, fluorescence imaging or x-ray. | 12-25-2014 |
| 536290120 | The acyclic nitrogen is part of a urea or thiourea group | 1 |
| 20120309954 | NON-IONIC ACID-LABILE SURFACTANTS AND METHODS OF USE - A compound may generally comprise the formula: | 12-06-2012 |
| 536290130 | Sulfur containing (e.g., sulfides, sulfones, sulfates, sulfonamides, etc.) | 2 |
| 20110245486 | METHOD FOR THE PRODUCTION OF 1,4-BENZOTHIEPIN-1,1-DIOXIDE DERIVATIVES - The invention relates to a method for producing 1,4-benzothiepin-1,1-dioxide derivatives substituted with benzyl groups. | 10-06-2011 |
| 20160075799 | A METHOD FOR PRODUCING ACTIVATED SUGAR CHAIN DERIVATIVE AND ACTIVATED SUGAR CHAIN DERIVATIVE PRODUCED THEREFROM - When manufacturing a sugar chain compound having an activating group, there was a problem with the ammonium carbonate method that is the conventional technology that during the process of introducing an amino group at the reducing terminal of the sugar chain, the unit sugar located at the reducing terminal of the sugar chain is subjected to ring-opening, thus causing a mixture of α and β anomers to be produced. The present invention provides a method for manufacturing a sugar chain compound having an activating group with high β selectivity using a compound having a sugar chain asparagine structure as the source material by cleaving the sugar chain from the sugar chain peptide so that the reducing terminal of the sugar chain and the nitrogen atom derived from the asparagine side chain will remain in a bound state, and introducing an activating group to said nitrogen atom while retaining not only the covalent bond between the reducing terminal of said sugar chain and said nitrogen atom but also the β configuration. A novel sugar chain compound which is a β anomer and has an activating group is also provided as a compound of the present invention. | 03-17-2016 |
